Evome Medical Technologies Inc.

LNDZFOTCHealthcare

$0.00

+$0.00(+0.00%)

Market Cap$5981

P/E Ratio—

52W High$0.006

52W Low$0.0001

Avg Volume10K

Open$0.00

Beta2.22

Earnings Financials Revenue

Evome Medical Technologies Inc. (LNDZF) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

LNDZF · earnings · updated Jun 9, 2026

Latest Earnings

Q4 FY2024Report Date: Nov 18, 2024

EPS Actual

-$0.01

Revenue

$0.01B

Fiscal Period

Q4 FY2024

FY ends December

Report Date

Nov 18, 2024

After Market Close

LNDZF reports quarterly as a OTC-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

$-0.11

Rev. $0.17B

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.$-0.11

Rev. Est.$0.17B

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q3 FY2026	Aug 18, 2026	—	—	—	—	—	—
◌ Q2 FY2026	Jun 9, 2026	—	—	—	—	—	—
◌ Q4 FY2025	Dec 29, 2025	—	—	—	—	—	—
◌ Q3 FY2025	Aug 28, 2025	—	—	—	—	—	—
◌ Q2 FY2025	May 29, 2025	—	—	—	—	—	—
◌ Q1 FY2025	Mar 28, 2025	—	—	—	—	—	—
— Q4 FY2024	Nov 18, 2024	—	-$0.01	—	$0.01B	—	—
— Q3 FY2024	Aug 12, 2024	—	-$0.02	—	$0.01B	—	—

Q3 FY2026

Aug 18, 2026

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2026

Jun 9, 2026

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2025

Dec 29, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2025

Aug 28, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2025

May 29, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2025

Mar 28, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2024

Nov 18, 2024

EPS Actual

-$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

$0.01B

Q3 FY2024

Aug 12, 2024

EPS Actual

-$0.02

EPS Est.

—

EPS Surpr.

—

Revenue

$0.01B

Analyst Estimates

Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.

EPS Estimates

Period	Low	Consensus	High	# Analysts
Q1 FY2023	$-0.06	$-0.06	$-0.06	1
Q2 FY2022	$-0.02	$-0.02	$-0.02	1

Revenue Estimates

Period	Low	Consensus	High	# Analysts
Q1 FY2023	$0.0B	$0.0B	$0.0B	1
Q2 FY2022	$0.0B	$0.0B	$0.0B	1

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q4 FY2024	Nov 18, 2024	—	$0.08	$0.08	+0.00%
— Q3 FY2024	Aug 12, 2024	—	$0.08	$0.09	+20.00%
— Q2 FY2024	Apr 16, 2024	—	$0.21	$0.10	-52.38%
— Q4 FY2023	Nov 15, 2023	—	$0.16	$0.16	+0.00%
— Q3 FY2023	Aug 15, 2023	—	$0.21	$0.21	+0.00%

Q4 FY2024+0.00%

Report Date

Nov 18, 2024

EPS Beat/Miss

—

Price Before

$0.08

Price After

$0.08

Q3 FY2024+20.00%

Report Date

Aug 12, 2024

EPS Beat/Miss

—

Price Before

$0.08

Price After

$0.09

Q2 FY2024-52.38%

Report Date

Apr 16, 2024

EPS Beat/Miss

—

Price Before

$0.21

Price After

$0.10

Q4 FY2023+0.00%

Report Date

Nov 15, 2023

EPS Beat/Miss

—

Price Before

$0.16

Price After

$0.16

Q3 FY2023+0.00%

Report Date

Aug 15, 2023

EPS Beat/Miss

—

Price Before

$0.21

Price After

$0.21

Beat Rate0 / 5 quarters

Largest Move-52.38% (Q2 FY2024)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Evome Medical Technologies Inc. (LNDZF) most recently reported earnings on November 18, 2024 for Q4 FY2024, posting EPS of $-0.01 (in line with the analyst consensus of —). The next LNDZF earnings date is expected around September 1, 2026.

Each quarter, investors track LNDZF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. LNDZF revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

LNDZF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

LNDZF earnings · 4 questions

Evome Medical Technologies Inc.'s next earnings report is expected around September 1, 2026. LNDZF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; LNDZF historically reports after market close (AMC).

LNDZF earnings datewhen is LNDZF earningsLNDZF next earnings datewhen does LNDZF report earningsLNDZF earnings calendar

▸ Source: FMP · Evome Medical Technologies Inc. SEC filings · US GAAP · Evome Medical Technologies Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026